SAM
NVCR icon

Smartleaf Asset Management’s NovoCure NVCR Stock Holding History

Smartleaf Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32K Hold
408
– – ﹤0.01% 2588
2026
Q1 		$4.23K Sell
408
-67
-14% -$837 ﹤0.01% 2732
2025
Q4 		$6.28K Buy
475
+268
+129% +$3.44K ﹤0.01% 2609
2025
Q3 		$2.67K Buy
207
+178
+614% +$2.38K ﹤0.01% 2537
2025
Q2 		$522 Sell
29
-224
-89% -$3.9K ﹤0.01% 2580
2025
Q1 		$4.77K Buy
253
+69
+38% +$1.57K ﹤0.01% 2202
2024
Q4 		$5.53K Sell
184
-155
-46% -$3.28K ﹤0.01% 2214
2024
Q3 		$5.29K Buy
339
+252
+290% +$4.57K ﹤0.01% 2094
2024
Q2 		$1.53K Buy
87
+36
+71% +$633 ﹤0.01% 2314
2024
Q1 		$746 Buy
+51
New +$750 ﹤0.01% 1675

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Smartleaf Asset Management's NVCR Position: Q2 2026 in Review

Smartleaf Asset Management held its NovoCure (NVCR) position steady in Q2 2026 at 408 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

Smartleaf Asset Management first reported a position in NVCR in Q1 2024 and has held it in 10 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Smartleaf Asset Management held 408 shares of NovoCure worth $6.32K as of Q2 2026.
  • Smartleaf Asset Management left its NovoCure share count unchanged in Q2 2026.
  • NovoCure made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2588 holding.
  • Smartleaf Asset Management first reported a position in NovoCure in Q1 2024 and has held it in 10 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.